- Unique identifier:
- Software type:
- Restrictions to use:
- Academic or non-commercial use
- Computer skills:
- Variant Annotation, Analysis and Search Tool
- Command line interface
- Operating system:
- Homo sapiens
- Mark Yandell <>
A registration is needed to access to tools.
No open topic.
(Kennedy et al., 2014)
Using VAAST to Identify Disease-Associated Variants in Next-Generation Sequencing Data.
Curr Protoc Hum Genet.
PMID: 24763993 DOI: 10.1002/0471142905.hg0614s81
(Hu et al., 2013)
VAAST 2.0: improved variant classification and disease-gene identification using a conservation-controlled amino acid substitution matrix.
PMID: 23836555 DOI: 10.1002/gepi.21743
(Rope et al., 2011)
Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency.
Am J Hum Genet.
PMID: 21700266 DOI: 10.1016/j.ajhg.2011.05.017
(Hu et al., 2014)
A unified test of linkage analysis and rare-variant association for analysis of pedigree sequence data.
PMID: 24837662 DOI: 10.1038/nbt.2895
Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA; Institute for Systems Biology, Seattle, WA, USA; Department of Psychiatry, University of Utah, Salt Lake City, UT, USA; Department of Pediatrics, University of Utah, Salt Lake City, UT, USA; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA; ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, UT, USA; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Department of Human Genetics and USTAR Center for Genetic Discovery, University of Utah, Salt Lake City, UT, USA; Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, NJ, USA; Department of Pediatrics, The Ohio State University, Columbus, OH, USA; Center for Cardiovascular and Pulmonary Research, Research Institute at Nationwide Children’s Hospital, Columbus, OH, USA; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg; Pacific Northwest Diabetes Research Institute, Seattle, WA, USA; Gladstone Institute of Cardiovascular Disease and University of California, San Francisco, San Francisco, CA, USA; Omicia, Inc., Oakland, CA, USA
Supported by US National Institutes of Health grants R01 GM104390, R01 DK091374, R01 CA164138, R44HG006579 and R01 GM59290, the University of Luxembourg—Institute for Systems Biology Program, grants from the NHLBI (UO1 HL100406 and U01 HL098179), NIH grants R01 MH094400 and R01 MH099134, the MD Anderson Cancer Center Odyssey Program and NIH grant R00HG005846.
0 user reviews
0 user reviews
No review has been posted.